These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23085503)

  • 1. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
    Jain N; Trivedi MH; Rush AJ; Carmody T; Kurian B; Toto RD; Sarode R; Hedayati SS
    Contemp Clin Trials; 2013 Jan; 34(1):136-44. PubMed ID: 23085503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
    BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD.
    Gregg LP; Carmody T; Le D; Bharadwaj N; Trivedi MH; Hedayati SS
    Kidney360; 2020 Jun; 1(6):436-446. PubMed ID: 35368605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.
    Gregg LP; Hedayati SS
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):457-464. PubMed ID: 32701597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
    Hedayati SS; Daniel DM; Cohen S; Comstock B; Cukor D; Diaz-Linhart Y; Dember LM; Dubovsky A; Greene T; Grote N; Heagerty P; Katon W; Kimmel PL; Kutner N; Linke L; Quinn D; Rue T; Trivedi MH; Unruh M; Weisbord S; Young BA; Mehrotra R
    Contemp Clin Trials; 2016 Mar; 47():1-11. PubMed ID: 26621218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
    Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
    Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.
    Möller HJ; Demyttenaere K; Olausson B; Szamosi J; Wilson E; Hosford D; Dunbar G; Tummala R; Eriksson H
    World J Biol Psychiatry; 2015 Oct; 16(7):483-501. PubMed ID: 25602163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.
    Schweizer E; Rynn M; Mandos LA; Demartinis N; García-España F; Rickels K
    Int Clin Psychopharmacol; 2001 May; 16(3):137-43. PubMed ID: 11354235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).
    Nagler EV; Webster AC; Vanholder R; Zoccali C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3736-45. PubMed ID: 22859791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
    Papakostas GI; Petersen T; Worthington JJ; Roffi PA; Alpert JE; Fava M; Nierenberg AA
    Int Clin Psychopharmacol; 2003 Sep; 18(5):293-6. PubMed ID: 12920390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
    Fabre LF; Abuzzahab FS; Amin M; Claghorn JL; Mendels J; Petrie WM; Dubé S; Small JG
    Biol Psychiatry; 1995 Nov; 38(9):592-602. PubMed ID: 8573661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
    Ramasubbu R
    Acta Psychiatr Scand; 2001 Sep; 104(3):236-8; discusiion 238-9. PubMed ID: 11531662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline effectiveness and safety in depressed oncological patients.
    Torta R; Siri I; Caldera P
    Support Care Cancer; 2008 Jan; 16(1):83-91. PubMed ID: 17874143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.